Allergies
Reports Outline Allergies Study Findings from Benioff Children's Hospital
Published in Gene Therapy Weekly, April 12th, 2012
2012 APR 12 -- According to the authors of a study from San Francisco, California, "The most profound primary immunodeficiency disease, severe combined immunodeficiency (SCID), is fatal in infancy unless affected infants are provided with an adaptive immune system through allogeneic hematopoietic cell transplantation, enzyme replacement, or gene therapy. However, most infants with SCID lack a family history or any clinical clues before the onset of infections, making this serious but treatable disease a candidate for population-based newborn screening."
"Of several approaches considered for SCID screening, testing for T-cell receptor excision circles...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2012-04-12)
More Articles from Gene Therapy Weekly
- Gene Therapy
Data on Gene Therapy Published by Researchers at Harvard University - Serum Globulins
Findings from Mayo Clinic in Serum Globulins Reported - Gene Therapy
Investigators at First Affiliated Hospital Release New Data on Gene Therapy - One-Carbon Group Transferases
Investigators at Michigan State University Report Research in One-Carbon Group Transferases - Vaccines
Investigators from Arizona State University Zero in on Vaccines - Allergies
Investigators from Duke University Have Published New Data on Allergies - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
